|Name||PRICE||MARKET CAPITALIZATION||PRICE TO EARNINGS RATIO||DIVIDEND YIELD||SYMBOL||EXCHANGE||PRICE PERCENT DIFFERENCE||YEAR TO DATE PRICE PERCENT DIFFERENCE||5 YEAR CHART||1 YEAR CHART|
Eli Lilly & Co [LLY]
$116.01 0.72 (0.62%)
Market Cap 113.93 Billion
Eli Lilly is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. Lilly's key products include Alimta for cancer; Forteo for osteoporosis; Jardiance, Trulicity, Humalog, and Humulin for diabetes; Taltz and Olumiant for immunology; and Cialis for erectile dysfunction.
EPS 4.33 P/E Ratio 40.60
Previous Earnings Tue, Apr 30, 2019
Latest Earnings Tue, Jul 30, 2019 (In 72 days)
Yield 2.22% / $2.58
Ex-Date Thu, May 16, 2019 (3 days ago)
Pay Date Mon, Jun 10, 2019
This list of trending stocks may change throughout the trading day.